A Safety, Tolerability, and Pharmacokinetic Clinical Trial of AX-024.HCl to Evaluate A) Potential Food Effect and B) Multi-dosing in Healthy Male Subjects

Trial Profile

A Safety, Tolerability, and Pharmacokinetic Clinical Trial of AX-024.HCl to Evaluate A) Potential Food Effect and B) Multi-dosing in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Feb 2016

At a glance

  • Drugs AX 024 (Primary)
  • Indications Asthma; Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors Artax Biopharma
  • Most Recent Events

    • 08 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 16 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top